Providers and suppliers alike gain valuable insight from Expo
MedAssetsMedia Contact:Robin Wrinn, 678-624-7420orInvestor Contact:Robert Borchert, 678-248-8194
MedAssets (NASDAQ: MDAS) today announced that it recently held its 12th annual Technology and Innovation Expo, which each year showcases the latest advancements in healthcare products and services designed to address pressing industry challenges. This year, 70 suppliers presented innovative, high-quality products and clinical technologies to more than 400 MedAssets provider clients, receiving valuable feedback on their offerings.
“In order to thrive in the evolving market, healthcare systems are looking for ways to innovatively reduce costs and align clinical delivery,” said Jim Connor, vice president, Supply Chain Operations, Westchester Medical Center. “MedAssets Technology and Innovation Expo provided our health system with the platform to visit with up and coming suppliers to learn how their products and services can help us achieve our overall goal of improving the patient experience while also lowering the cost of care delivery.”
As part of MedAssets ongoing commitment to innovative strategies to help providers enhance operational and financial performance improvement, suppliers were invited to exhibit based on several criteria including: differentiating products or services designed to support quantifiable reductions in supply chain cost; introduce significant or technological or clinical advancements, or present substantial opportunity to improve patient outcomes and the overall delivery of patient care. Suppliers receiving a high score from MedAssets clients and that meet contracting eligibility guidelines will continue through the sourcing process for consideration to be added to the MedAssets national contract portfolio, which is comprised of more than 1,800 companies.
For more than a decade, MedAssets has been challenging the convention and helping push the healthcare industry forward,” said Keith Thurgood, president, Spend and Clinical Resource Management, MedAssets. “This year’s Technology and Innovation Expo afforded our provider clients the opportunity to collaborate with healthcare suppliers and exemplifies our ongoing commitment to invest in innovative technologies and solutions designed to help our clients reduce the total cost of care, enhance operational efficiencies, align clinical delivery and improve revenue performance.”
Westchester Medical Center is home to the region’s only heart transplant program. It is one of only five hospitals in the State that perform heart transplants. It is home to the region's only heart and vascular program, Westchester Heart and Vascular—a multi-specialty cardiology practice dedicated to providing comprehensive, high-quality cardiac and vascular services to the residents of Westchester and the Hudson Valley. Westchester Heart and Vascular brings the clinical expertise of some of the nation’s finest cardiologists, cardiothoracic surgeons and vascular surgeons together in one practice with multiple locations in Westchester as well as offices throughout the Hudson Valley. For more information, please visit .
MedAssets (NASDAQ: MDAS) helps healthcare organizations to improve financial strength through innovative revenue cycle, spend and clinical resource management solutions that enable improved margins, cash flow, quality of care and patient satisfaction. More than 4,200 hospitals and 122,000 non-acute healthcare providers currently use the company’s Web-based technologies and evidence-based solutions to help capture revenue, control cost, increase regulatory compliance and optimize operational efficiency to improve the care delivery process. As a result, the company manages annually $50 billion in healthcare supply spend and touches over $365 billion in gross patient revenues. For more information, please visit .